Clik here to view.
Epigenomics and Companion Diagnostics
Larry H Bernstein, MD, FCAP, Reporter and Curator http://pharmaceuticalintelligence.com/2013-12-07/larryhbern/Epigenomics and Companion Diagnostics The development of epigenomics has reached a new...
View ArticleClik here to view.
Notes On Tumor Heterogeneity: Targets and Mechanisms, from the 2015 AACR...
Notes On Tumor Heterogeneity: Targets and Mechanisms, from the 2015 AACR Meeting in Philadelphia PA Reporter: Stephen J. Williams, Ph.D. The following contain notes from the Sunday April 19, 2015 AACR...
View ArticleClik here to view.
3 Dimensional Ex vivo Technique for In situ Tumor Growth
3 Dimensional Ex vivo Technique for In situ Tumor Growth Reporter: Stephen J. Williams, Ph.D. Brain tumors are both difficult to treat and hard to study because of the organ they affect. The structure...
View ArticleClik here to view.
How cancer metastasis occurs
How cancer metastasis occurs Larry H. Bernstein, MD, FCAP, Curator LPBI How Cancer Cells Slide along Narrow Path to Metastasis...
View ArticleClik here to view.
Recent progress in neurodegenerative diseases and gliomas
Recent progress in neurodegenerative diseases and gliomas Curator: Larry H. Bernstein, MD, FCAP LPBI Alzheimer’s Protein Not All Bad, Says MassGen Study A controversial idea—that amyloid-beta (Aβ)...
View ArticleLive Conference Coverage @Medcitynews Converge 2018 Philadelphia: The Davids...
Live Conference Coverage @Medcitynews Converge 2018 Philadelphia: The Davids vs. the Cancer Goliath Part 2 8:40 – 9:25 AM The Davids vs. the Cancer Goliath Part 2 Startups from diagnostics, biopharma,...
View ArticleImmunotherapy may help in glioblastoma survival
Reporter and Curator: Dr. Sudipta Saha, Ph.D. Glioblastoma is the most common primary malignant brain tumor in adults and is associated with poor survival. But, in a glimmer of hope, a recent study...
View ArticleReal Time Coverage @BIOConvention #BIO2019: International Cancer Clusters...
Real Time Coverage @BIOConvention #BIO2019: International Cancer Clusters Showcase June 3 Philadelphia PA Reporter: Stephen J. Williams PhD @StephenJWillia2 Larry Blandford PharmD from Precision...
View ArticleInhibitory CD161 receptor recognized as a potential immunotherapy target in...
Inhibitory CD161 receptor recognized as a potential immunotherapy target in glioma-infiltrating T cells by single-cell analysis Reporter: Dr. Premalata Pati, Ph.D., Postdoc Brain tumors, especially...
View Article
